News

Medical campus update: Hurricane Irma

The latest on Hurricane Irma and how it is affecting the medical campus.

Read more »

A Scholar Rock antibody (in orange) is shown binding to the myostatin precursor (in green and yellow) to prevent release of myostatin's muscle growth-prevention activity.

Drug Candidate Shows Therapeutic Potential in Preclinical Model of Spinal Cord Injury

The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine and Scholar Rock, a biotechnology company, have announced findings from a research collaboration that has demonstrated beneficial effects of a proprietary antibody in a preclinical model of spinal cord injury.

Read more »

From left, Hilit F. Mechaber, M.D., Nanette Vega, M.A., Ivette Motola, M.D., M.P.H., and Stephen Symes, M.D.

Honoring Women in Academic Medicine and Their Achievements

Women in Academic Medicine, the Office of Diversity and Inclusion, and the Committee of Interns and Residents at the University of Miami Miller School of Medicine hosted the annual Evening of Fellowship on January 23, honoring recent successes and achievements of the Miller School’s women faculty. The event began with networking among attendees from various departments, including many chairs and center directors.

Read more »

Amar R. Deshpande, M.D.

Next-Generation Medical Education Task Force to Design the Ideal Training for Doctors of the Future

As medicine and the delivery of health care continue to be transformed, the University of Miami Miller School of Medicine — already a national leader in innovative education — is taking a global look at transforming the entire medical curriculum. And Amar R. Deshpande, M.D., who is leading the charge as chair of the Next Generation Medical Education Task Force, says the timing couldn’t be better.

Read more »

From left, Diana D. Cardenas, M.D., M.H.A., Elizabeth R. Felix, Ph.D., and Mark S. Nash, Ph.D.

Miller School Researchers Receive Spinal Cord Rehabilitation Grant

A team of Miller School researchers will be studying neuropathic pain in patients with spinal cord injuries after receiving a $2.4 million five-year grant from the National Institute on Disability and Rehabilitation Research.

Read more »